New OTC product with unique technology to help allergy sufferers

GSK launches Flonase Sensimist allergy relief nationwide.

With unique MistPro technology, Flonase Sensimist delivers a fine, gentle, yet powerful mist spray, providing non-drowsy, 24-hour relief of allergy symptoms including itchy, watery eyes, nasal congestion, runny or itchy nose and sneezing.

Taken once daily, directly in the nose, the treatment protects against allergies caused by triggers including pollen, mold, dust and pets. Unlike most OTC allergy pills, which act on histamine alone, Flonase Sensimist helps block six key inflammatory substances; it has also been found to be 40% stronger than a leading non-drowsy allergy pill.

"For the more than 50 million Americans who suffer from allergies, the burden is more than just a stuffy nose," said Dr Clifford Bassett, Founder and Medical Director of Allergy & Asthma Care of New York. "Uncontrolled allergies have a measurable impact on quality of life, affecting children and adults. In my patient population, having a proactive treatment plan in place makes a big difference in managing their allergies."

Additional key features of Flonase Sensimist's unique, ergonomic design include

Previously available by prescription only, Flonase Sensimist was approved by FDA for OTC availability in August 2016. Sensimist joins Flonase Allergy Relief and Children's Flonase Allergy Relief in the Flonase product family, offering a comfortable spray experience so consumers can pick what they prefer.

"GSK Consumer Healthcare has a strong heritage in discovering and developing respiratory products to meet patient needs worldwide," said Jennifer Nadelson, Senior Brand Manager, Flonase. "With Flonase Sensimist, we're proud to offer allergy sufferers an additional product option providing more complete symptom reliefi in a new, unique, user-friendly device."